KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to 0.42.

  • Novartis Ag's Equity Ratio fell 278.38% to 0.42 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.42, marking a year-over-year decrease of 278.38%. This contributed to the annual value of 0.42 for FY2025, which is 278.38% down from last year.
  • As of Q4 2025, Novartis Ag's Equity Ratio stood at 0.42, which was down 278.38% from 0.01 recorded in Q1 2025.
  • In the past 5 years, Novartis Ag's Equity Ratio ranged from a high of 0.51 in Q4 2021 and a low of 0.01 during Q1 2022
  • In the last 5 years, Novartis Ag's Equity Ratio had a median value of 0.01 in 2025 and averaged 0.22.
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 1504.25% in 2021, then tumbled by 773.7% in 2024.
  • Over the past 5 years, Novartis Ag's Equity Ratio (Quarter) stood at 0.51 in 2021, then dropped by 1.69% to 0.51 in 2022, then dropped by 7.55% to 0.47 in 2023, then decreased by 7.74% to 0.43 in 2024, then dropped by 2.78% to 0.42 in 2025.
  • Its Equity Ratio was 0.42 in Q4 2025, compared to 0.01 in Q1 2025 and 0.43 in Q4 2024.